- Clots and OCPs10:23Paper Chase #1 | Diclofenac and CV Risks5:55Hypertensive Disorders of PregnancyFree Chapter20:55Pediatric Stroke27:34Paper Chase #2 | Screening for cervical cancer: USPSTF recommendation statement3:02Tremor: A Diagnostic Approach17:25NOTALGIA and MERALGIA PARESTHETICA10:43Paper Chase #3 | Aspirin and CVD Prevention4:19Essential Tremor: Treatment7:28Observation Care17:41Paper Chase #4 | Risks/benefits of Direct Oral Anticoagulants versus Warfarin3:24Sickle Cell Emergencies21:48ACE vs ARB10:08Paper Chase #5 | Anticonvulsants in the Treatment of Low Back Pain3:03The Summary13:55
Paper Chase #4 | Risks/benefits of Direct Oral Anticoagulants versus Warfarin
No me gusta!
The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.
BOTTOM LINE: Overall, apixaban was found to be the safest drug, with reduced risks of major, intracranial, and gastrointestinal bleeding compared with warfarin. Rivaroxaban and low dose apixaban were associated with increased risks of all cause mortality compared with warfarin.